Written by: Natalie R. Bavli, M.D.Adam J. Kanack, Ph.D.Yoshito Nishimura, M.D.Noah P. Splinter, M.S.Emily E. Mauch, B.S.Alessandra J. Ainsworth, M.D.Ravi Sarode, M.D.Robert D. McBane, M.D.Mindy C. Kohlhagen, B.S.David Murray, M.D., Ph.D.Dong Chen, M.D., Ph.D.Rajiv K. Pruthi, M.B., B.S.Anand Padmanabhan, M.B., B.S., Ph.D.
Two patients with monoclonal anti-PF4 antibodies, thrombosis, and chronic thrombocytopenia also had first-trimester pregnancy losses, findings that suggest a possible link between these antibodies and obstetrical complications.
NB
Dr. Natalie Bavli
Classical HematologyThe University of Texas Southwestern Medical Centernatalieb